FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

116096001: Rosiglitazone maleate (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
177440011 Rosiglitazone maleate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
674905017 Rosiglitazone maleate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
177440011 Rosiglitazone maleate en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core
177440011 Rosiglitazone maleate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
674905017 Rosiglitazone maleate (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
674905017 Rosiglitazone maleate (substance) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT core
674905017 Rosiglitazone maleate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
36131000188112 rosiglitazone maléate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
838871000172115 maléate de rosiglitazone fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
36131000188112 rosiglitazone maléate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
838871000172115 maléate de rosiglitazone fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Rosiglitazone maleate (substance) Is a Thiazolidinedione (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
Rosiglitazone maleate (substance) Is a Thiazolidinedione (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Rosiglitazone maleate (substance) Is a Rosiglitazone (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
Rosiglitazone maleate (substance) Has disposition Peroxisome proliferator-activated gamma receptor agonist (disposition) true Inferred relationship Existential restriction modifier (core metadata concept)
Rosiglitazone maleate (substance) Is modification of (attribute) Rosiglitazone (substance) true Inferred relationship Existential restriction modifier (core metadata concept)

Inbound Relationships Type Active Source Characteristic Refinability Group
Rosiglitazone (as rosiglitazone maleate) 8 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Rosiglitazone maleate (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Rosiglitazone (as rosiglitazone maleate) 4 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Rosiglitazone maleate (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Rosiglitazone maleate 2mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Rosiglitazone maleate (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Rosiglitazone maleate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Rosiglitazone maleate (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely rosiglitazone maleate 2 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Rosiglitazone maleate (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely glimepiride 1 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Rosiglitazone maleate (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely glimepiride 2 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Rosiglitazone maleate (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 1 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Rosiglitazone maleate (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Metformin hydrochloride 500 mg and rosiglitazone (as rosiglitazone maleate) 2 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Rosiglitazone maleate (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely metformin hydrochloride 1 gram and rosiglitazone (as rosiglitazone maleate) 2 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Rosiglitazone maleate (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely metformin hydrochloride 1 gram and rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Rosiglitazone maleate (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Rosiglitazone maleate (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Rosiglitazone maleate (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Rosiglitazone (as rosiglitazone maleate) 8 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Rosiglitazone maleate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Rosiglitazone (as rosiglitazone maleate) 4 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Rosiglitazone maleate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 1 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Rosiglitazone maleate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet Has basis of strength substance (attribute) False Rosiglitazone maleate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely metformin hydrochloride 1 gram and rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Rosiglitazone maleate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely rosiglitazone maleate 2 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Rosiglitazone maleate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely rosiglitazone maleate 2 milligram/1 each conventional release oral tablet Has basis of strength substance (attribute) False Rosiglitazone maleate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely glimepiride 2 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Rosiglitazone maleate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely glimepiride 2 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet Has basis of strength substance (attribute) False Rosiglitazone maleate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Rosiglitazone maleate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet Has basis of strength substance (attribute) False Rosiglitazone maleate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Metformin hydrochloride 500 mg and rosiglitazone (as rosiglitazone maleate) 2 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Rosiglitazone maleate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Rosiglitazone maleate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet Has basis of strength substance (attribute) False Rosiglitazone maleate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely metformin hydrochloride 1 gram and rosiglitazone (as rosiglitazone maleate) 2 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Rosiglitazone maleate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely glimepiride 1 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Rosiglitazone maleate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely glimepiride 1 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet Has basis of strength substance (attribute) False Rosiglitazone maleate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 1 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Rosiglitazone maleate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet Has precise active ingredient False Rosiglitazone maleate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet Has precise active ingredient False Rosiglitazone maleate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Rosiglitazone (as rosiglitazone maleate) 8 mg oral tablet Has precise active ingredient True Rosiglitazone maleate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Rosiglitazone (as rosiglitazone maleate) 4 mg oral tablet Has precise active ingredient True Rosiglitazone maleate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely glimepiride 2 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet Has precise active ingredient False Rosiglitazone maleate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Metformin hydrochloride 500 mg and rosiglitazone (as rosiglitazone maleate) 2 mg oral tablet Has precise active ingredient False Rosiglitazone maleate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely metformin hydrochloride 1 gram and rosiglitazone (as rosiglitazone maleate) 2 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Rosiglitazone maleate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely metformin hydrochloride 1 gram and rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient False Rosiglitazone maleate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely rosiglitazone maleate 2 milligram/1 each conventional release oral tablet Has precise active ingredient False Rosiglitazone maleate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely glimepiride 1 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet Has precise active ingredient False Rosiglitazone maleate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Metformin hydrochloride 500 mg and rosiglitazone (as rosiglitazone maleate) 2 mg oral tablet Has precise active ingredient True Rosiglitazone maleate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet Has precise active ingredient False Rosiglitazone maleate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely metformin hydrochloride 1 gram and rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Rosiglitazone maleate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely glimepiride 2 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet Has precise active ingredient False Rosiglitazone maleate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely glimepiride 2 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet Has basis of strength substance (attribute) False Rosiglitazone maleate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet Has precise active ingredient False Rosiglitazone maleate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet Has basis of strength substance (attribute) False Rosiglitazone maleate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely glimepiride 1 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet Has basis of strength substance (attribute) False Rosiglitazone maleate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely glimepiride 1 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet Has precise active ingredient False Rosiglitazone maleate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely glimepiride 4 milligram and rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Rosiglitazone maleate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Glimepiride 2 mg and rosiglitazone (as rosiglitazone maleate) 4 mg oral tablet Has precise active ingredient True Rosiglitazone maleate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Glimepiride 1 mg and rosiglitazone (as rosiglitazone maleate) 4 mg oral tablet Has precise active ingredient True Rosiglitazone maleate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely rosiglitazone (as rosiglitazone maleate) 2 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Rosiglitazone maleate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely glimepiride 2 milligram and rosiglitazone (as rosiglitazone maleate) 8 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Rosiglitazone maleate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Glimepiride 4 mg and rosiglitazone (as rosiglitazone maleate) 8 mg oral tablet Has precise active ingredient True Rosiglitazone maleate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Rosiglitazone maleate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2

This concept is not in any reference sets

Back to Start